MONOPHARMA
Start SIP
Invest Now
Start SIP in MONOPHARMA
Performance
- Low
- ₹16
- High
- ₹16
- 52 Week Low
- ₹15
- 52 Week High
- ₹35
- Open Price₹16
- Previous Close₹15
- Volume2,000
Investment Returns
- Over 1 Month -21.25%
- Over 3 Month -28.41%
- Over 6 Month -35.71%
- Over 1 Year -54.55%
Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!
Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 9
- PEG Ratio
- -
- Market Cap Cr
- 28
- P/B Ratio
- 0.9
- Average True Range
- 0.84
- EPS
- 1.75
- Dividend Yield
- 0
- MACD Signal
- -1.22
- RSI
- 32.35
- MFI
- 21.43
Mono Pharmacare Financials
Mono Pharmacare Technicals
EMA & SMA
Current Price
₹15.75
+
0.55
(3.62%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹17.96
- 50 Day
- ₹20.08
- 100 Day
- ₹22.23
- 200 Day
- ₹26.33
Resistance and Support
15.75
- R3 15.75
- R2 15.75
- R1 15.75
- S1 15.75
- S2 15.75
- S3 15.75
Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-29 | Quarterly Results & Others | To consider other business matters (Revised) |
| 2025-08-26 | Others | To consider other business matters |
| 2025-05-30 | Audited Results & Others | (Revised) To consider other business matters. |
| 2025-04-11 | Others | To consider other business matters (Revised) |
| 2025-02-10 | Others | To consider other business matters |
Mono Pharmacare F&O
About Mono Pharmacare
- NSE Symbol
- MONOPHARMA
- BSE Symbol
- Managing Director
- Mr. Panilam Lakhatariya
- ISIN
- INE0OIP01012
Similar Stocks to Mono Pharmacare
Mono Pharmacare FAQs
Mono Pharmacare share price is ₹15 As on 27 December, 2025 | 08:54
The Market Cap of Mono Pharmacare is ₹27.8 Cr As on 27 December, 2025 | 08:54
The P/E ratio of Mono Pharmacare is 9 As on 27 December, 2025 | 08:54
The PB ratio of Mono Pharmacare is 0.9 As on 27 December, 2025 | 08:54
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.